Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Of U.K. To Put $100 Million Into R&D Center For Neuroscience Center (China)

This article was originally published in PharmAsia News

Executive Summary

U.K.-based GlaxoSmithKline plans to develop a $100 million neuroscience research center in China as a key element in its global drug-development strategy. The company's research-and-development head said the intention is to have the center be responsible for all work on neuro-degenerative diseases for treating diseases such as Alzheimer's, Parkinson's and multiple sclerosis. Moncef Sioui said GSK no longer sees China as an outsourcing and cheap-labor center, but now one capable of "different science." Several other global drug firms also are eying significant R&D investments in China. (Click here for more ) "GSK In $100 Million China Push" Financial Times (U.K.) (12/13/07)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065868

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel